Company intelligence / Profile preview

Europeptides

Illkirch-Graffenstaden, Grand Est, France

Ownership: Private
Development stage: Other

Overview

EuroPeptides was a French biotechnology company specializing in the design, synthesis, and production of high-quality peptides for pharmaceutical and research applications. Based in the Strasbourg region, the company focused on custom peptide synthesis and the development of peptide-based therapeutic candidates. It operated as a specialized contract manufacturing and research organization before being integrated into larger pharmaceutical groups. The company's expertise primarily served the early-stage drug discovery and development needs of the European life sciences industry.

Modalities: Peptides
Industry: Drug Discovery Services

Partnerships

UCBLonza

Beyond the preview

Go deeper on Europeptides.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Europeptides.

Explore the full profile